The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.

Giancarlo Agnelli, Daniel J. George, W. Fisher, A. K. Kakkar, M. R. Lassen, P. Mismetti, Patrick Mouret, Umesh Chaudhari, A. G. G. Turpie

Journal of Clinical Oncology · 2011 · 10 citations · 0 references

Concepts

Abstract

LBA9014 The full, final text of this abstract will be available in Part II of the 2011 Annual Meeting Proceedings, distributed onsite at the Meeting on June 4, 2011, and as a supplement to the June 20, 2011, issue of Journal of Clinical Oncology.